About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. José Luis García Giménez. Dept. Physiology. Medicine and Dentistry School, University of Valencia. Biomedical Research Institute INCLIVA CIBERER-ISCIII
Epigenetic mechanisms control the activation or inactivation of gene expression, without changes in the DNA sequence, which consequently provides a finely tuned response capacity for cells and organisms when undergoing external and internal changes. However, in the context of human physiology or disease, any cellular imbalance that modulates homeostasis has the potential to trigger molecular changes that result either in physiological adaptation to a new situation or pathological conditions. Sepsis can directly impact epigenetic mechanisms at different levels, including DNA methylation, post-translational modifications and even produce the release of histones from cells to the blood-stream. In this lecture I will focus on the changes occurring in the DNA methylation profile of septic patients and how the release of extracellular histones produces severe deleterious effects on cells and tissues activating inflammation, oxidative stress, and cell death, so contributing to endothelial damage and endothelial dysfunction. In addition, I will provide evidence of the potential use of circulating histones determination can help in sepsis and septic shock patient management as well as, to provide new therapeutic strategies based on the removal of extracellular histones.
Host; Dr. Juan Carlos Ruiz, Head Clinic, Intensive Medicine Service. Vall d'Hebron University Hospital. Shock, Organ Dysfunction and Resuscitation Research Group (SODIR). Vall d'Hebron Research Institute (VHIR)
Register here to attend by Zoom: https://gencat.zoom.us/j/92863787346